
Though elderly patients represent a majority of cancer patients, their treatment of is still zzso mainly due to the lack of data zzso from zzso clinical zzso zzso limiting the use of standard chemotherapy regimens in elderly cancer patients are the fear of toxicity and unexpected side zzso The assessment of zzso and the zzso geriatric assessment are of major importance in the decision zzso All supportive measures must be adopted in order to successfully treat vulnerable and unfit elderly patients with cancer, and in particular, the use of growth factors when chemotherapy is given with zzso zzso rule out anemia and possible causes of zzso and correct them whenever zzso choose zzso according to expected adverse events and possible interference with zzso zzso zzso attention must be paid to treatment of pain in the elderly with zzso zzso must be involved in the treatment plan, and phone contacts with the patient and zzso are needed to verify physical conditions and compliance to zzso 

